Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05967273 · ClinicalTrials.gov registry record · NA
CirrhosisRx CDS System
A NA study of Cirrhosis and Decision Support Systems, Clinical, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- NA
- Development phase
- 2,106
- Enrollment target
- 1
- Study location
NCT05967273: Recruiting NA study of Cirrhosis and Decision Support Systems, Clinical, sponsored by University of California, San Francisco.
NCT05967273 is a NA study of Cirrhosis and Decision Support Systems, Clinical that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 2,106 participants, below the 90,369-participant average among 53 other Cirrhosis trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05967273, a NA study of Cirrhosis and Decision Support Systems, Clinical, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- NA
- Development phase
- 2,106 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of the study is to compare the effect of CirrhosisRx, a novel clinical decision support (CDS) system for inpatient cirrhosis care, versus "usual care" on adherence to national quality measures and clinical outcomes for hospitalized patients with cirrhosis.
Primary Outcome
This outcome is the aggregate adherence to five American Gastroenterological Association (AGA) and American Association for the Study of Liver Disease (AASLD) quality measures applicable to hospitalized patients with cirrhosis. The calculation for the measure will be the total number of admissions satisfying the five AGA/AASLD quality measures divided by the total number of addressable admissions (e.g. hospitalizations in which these quality metrics could be applied). In the cases which an admis
Conditions Studied
Interventions
- OTHER CirrhosisRx CDS
Study Locations (1)
California
- University of California San Francisco Medical Center - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,106 participants |
| Start Date | 2025-01-14 |
| Est. Completion | 2027-06 |
| Phase | NA |
What NCT05967273 shows while recruiting
NCT05967273 is an interventional study that assigns participants to a tested intervention. Its 2,106 participants enrollment target places it among the larger protocols in the corpus, below the 90,369-participant average among 53 other Cirrhosis trials with a reported enrollment target (98% lower).
The record links to 2 conditions, with Cirrhosis appearing as the primary indexed condition, and to 1 intervention - of which CirrhosisRx CDS is the first listed.
NCT05967273 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05967273 about?
NCT05967273 is a clinical study titled "CirrhosisRx CDS System". The aim of the study is to compare the effect of CirrhosisRx, a novel clinical decision support (CDS) system for inpatient cirrhosis care, versus "usual care" on adherence to national quality measures and clinical outcomes for hospitalized patients with cirrhosis.
What is the current status of trial NCT05967273?
This trial is currently recruiting. It is a NA study. The enrollment target is 2,106 participants. The study started on 2025-01-14. Estimated completion is 2027-06.
What conditions does trial NCT05967273 study?
This clinical trial studies the following conditions: Cirrhosis, Decision Support Systems, Clinical.
What interventions are being tested in trial NCT05967273?
The interventions under investigation include: CirrhosisRx CDS (OTHER).
Who is sponsoring clinical trial NCT05967273?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05967273 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cirrhosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05967273's enrollment target sits among peer trials
2,106 4th of 53 higher than 50 of 53 other Cirrhosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cirrhosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
LiverSleep: A Behavioral Sleep Intervention for Patients With Cirrhosis and Insomnia
RECRUITING · NA
-
Copper Supplementation in Cirrhosis
RECRUITING · NA
-
HepHospital: A Pilot Trial of a Hepatology Home Hospital Intervention for Patients With Advanced Liver Disease
RECRUITING · NA
-
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
RECRUITING · NA
-
Microbiome Modulation With Prebiotics in PTSD and Cirrhosis
RECRUITING · NA
-
Adverse Outcomes and Mortality in Liver Transplant
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04649242 · 2,100 participants · Phase 3
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- NCT05206331 · 2,100 participants · Phase 4
CEM to Reduce Biopsy Rates for Less Than Highly Suspicious Breast Abnormalities: a Prospective Study
- NCT05270499 · 2,100 participants
Aveir VR Real-World Evidence Post-Approval Study
- NCT06324981 · 2,100 participants · NA
Using AI Text Messaging to Improve AHA's Life's Essential 8 Health Behaviors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI